Ladja, Alrasid T.

HRN: 21-51-88  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2022
CEFUROXIME 750MG (VIAL)
06/29/2022
07/06/2022
IV
750mg
Q8H
Fracture

 Indication:  Empiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Non-compliant To Guidelines